Pharmaceuticals, Biotechnology and Life Sciences
JUPITER, Fla., Oct. 27, 2021 (GLOBE NEWSWIRE) — Dyadic International, Inc. (“Dyadic”, “we”, “us”, “our”, or the “Company”) (NASDAQ: DYAI),…
Alan Fuhrman, experienced biotech executive and Checkmate board member, appointed as interim President and CEOCAMBRIDGE, Mass., Oct. 27, 2021 (GLOBE…
DURHAM, N.C., Oct. 27, 2021 (GLOBE NEWSWIRE) — Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in…
Saint Herblain (France), October 27, 2021 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, today announced…
NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, THE HONG KONG SPECIAL ADMINISTRATIVE REGION OF THE…
ENCINITAS, Calif., Oct. 25, 2021 (GLOBE NEWSWIRE) — Ventyx Biosciences, Inc. (Nasdaq: VTYX), a clinical-stage biopharmaceutical company focused on advancing…
AnaptysBio to receive $250 million upfront cash payment from Sagard Healthcare Royalty PartnersSagard to receive AnaptysBio’s 8% royalty on annual…
Biosimulation tool to conduct ‘what-if’ scenarios with virtual patients recognized in Software/Services categoryPRINCETON, N.J., Oct. 25, 2021 (GLOBE NEWSWIRE) —…
Data from a new sub-analysis of the Phase 1b/2a study in NASH shows correlation between increased liver fat and spleen…
– First-ever clinical activity data reported on 4D-310 Fabry disease product candidate utilizing the proprietary C102 targeted and evolved vector…